【最新】自拟方_号治疗慢性溃疡性结肠炎_宋丽【原创精品】---厌食.pdfVIP

第 1 1 卷 第 1 2 期 辽 宁 中 医 药 大 学 学 报 Vol. 11 No. 12 2009 年 12 月 JOURNAL OF LIAONING UNIVERSITY OF TCM Dec . ，2009 自拟方Ⅲ号治疗慢性溃疡性结肠炎 宋　丽 （南阳市宛城区第一人民医院，河南 南阳 473000 ） 摘 要：目的：观察自拟方Ⅲ号治疗慢性溃疡性结肠炎的疗效。方法：对入选的 180 例患者随机分为治疗组 120 例，对照组 60 例，治疗组采用自拟方Ⅲ号治疗，对照组采用常规西药复方苯乙哌啶，黄连素治疗，2 周为 1 个疗 程，治疗 2 个疗程，评定疗效。结果：治疗组总有效率 97.5%，对照组 83.33%，两组比较差异有显著性意义（P 0.05）。 结论：自拟方Ⅲ号治疗慢性溃疡性结肠炎临床效果明显。 关键词：自拟方Ⅲ号；慢性溃疡性结肠炎；疗效观察 ( ) 中图分类号：R574.62 文献标识码：B 文章编号：1673-842X 2009 12- 0111- 02 Chronic Ulcerative Colitis Treated by No.3 Prescription Formulated SONG Li （Wancheng District First Peoples Hospital of Nanyang, Nanyang 473000, Henan, China） Objective : To Observe the effect of No.3 prescription formulated by the author in treating Abstract： Chronic Ulcerative Colitis. Methods : All the patients involved in this study were randomly divided into the treatment group (120 cases) and the comparison group (60 cases). The treatment group was treated by No.3 prescription formulated by the author and the comparison group was treated by the routine Western medicine of Compound Diphenoxylate and Berberine. The effects of the two methods were evaluated after two courses for two weeks as a course. Results: The total curative efficient of treatment group is 97.5% and the comparison group is 83.33% (P0.05).Conclusion: The clinical effect of No.3 method formulated by the author is remarkable. No.3 prescription formulated; Chronic Ulcerative Colitis; Observation of treatment effect Key words： 慢性溃疡性结肠炎是一种原因不明的肠道疾